BioGeneriX, a division of Teva Pharmaceuticals, focuses on the preclinical and clinical development of biosimilars.
Company (Alive / Active)
Phone:
Germany
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Method of producing and purifying an active soluble sialyltransferase | Feb 02, 2011 | Dec 29, 2015 | Patent |
Liquid formulation of g-csf | Oct 02, 2013 | Feb 03, 2015 | Patent |
Method for obtaining biologically active recombinant human g-csf | Mar 17, 2011 | Apr 22, 2014 | Patent |
Liquid formulations of g-csf | Aug 27, 2008 | Oct 22, 2013 | Patent |
Liquid formulation of g-csf conjugate | Aug 27, 2008 | Oct 01, 2013 | Patent |